Literature DB >> 17676265

Reasons for non-disclosure of faecal incontinence: a comparison between two survey methods.

L Bartlett1, M Nowak, Y H Ho.   

Abstract

PURPOSE: We explored reasons for discordance in disclosure of faecal incontinence (FI) between 2 measurement instruments: the Self Administered Faecal Incontinence Questionnaire (SAFIQ) and the Cleveland Clinic Florida Fecal Incontinence Score (CCF-FI)
METHODS: Patients >or=18 years attending the urogynaecology (n=135) and colorectal (n=148) outpatient clinics at The Townsville Hospital, a referral centre serving regional North Queensland, Australia, were invited to complete the SAFIQ and answer questions from the CCF-FI asked by their treating doctor. Selected patients undertook semistructured interviews.
RESULTS: 262 patients completed both questionnaires. The prevalence of FI in this population was 25.6% (SAFIQ) and 29.9% (CCF-FI). 24% disclosed FI on both instruments, 3.1% on SAFIQ only and 6.1% on CCF-FI only. Major reasons for non-disclosure were: FI historical but not current; problem not considered as FI by patient; SAFIQ too long; condition embarrassing; doctor considered too busy; patient wanted to focus on primary reason for consultation; and doctor explained that a one-off bout of uncontrollable diarrhoea was not FI. Interviewees reported they would respond to FI questions initiated by their general practitioner (GP) during regular consultations, or in a generic questionnaire in the GP's surgery.
CONCLUSIONS: GPs could identify patients with FI by initiating discussions during routine consultations. Such patients could then be referred to colorectal surgeons for treatment. A more specific definition of FI, which excludes historical data and isolated instances of diarrhoea, is desirable. A measurement instrument suitable for population surveys should contain simple language and acknowledge issues of embarrassment.

Entities:  

Mesh:

Year:  2007        PMID: 17676265     DOI: 10.1007/s10151-007-0360-z

Source DB:  PubMed          Journal:  Tech Coloproctol        ISSN: 1123-6337            Impact factor:   3.781


  25 in total

1.  Fecal Incontinence Quality of Life Scale: quality of life instrument for patients with fecal incontinence.

Authors:  T H Rockwood; J M Church; J W Fleshman; R L Kane; C Mavrantonis; A G Thorson; S D Wexner; D Bliss; A C Lowry
Journal:  Dis Colon Rectum       Date:  2000-01       Impact factor: 4.585

Review 2.  Epidemiology of fecal incontinence.

Authors:  Richard L Nelson
Journal:  Gastroenterology       Date:  2004-01       Impact factor: 22.682

Review 3.  Etiology and management of fecal incontinence.

Authors:  J M Jorge; S D Wexner
Journal:  Dis Colon Rectum       Date:  1993-01       Impact factor: 4.585

4.  Prevalence of faecal incontinence and associated risk factors; an underdiagnosed problem in the Australian community?

Authors:  Jamshid S Kalantar; Stuart Howell; Nicholas J Talley
Journal:  Med J Aust       Date:  2002-01-21       Impact factor: 7.738

Review 5.  The prevalence of fecal incontinence in community-dwelling adults: a systematic review of the literature.

Authors:  Alexandra K Macmillan; Arend E H Merrie; Roger J Marshall; Bryan R Parry
Journal:  Dis Colon Rectum       Date:  2004-08       Impact factor: 4.585

Review 6.  The perspective of the patient.

Authors:  Nancy J Norton
Journal:  Gastroenterology       Date:  2004-01       Impact factor: 22.682

7.  Prevalence of gastrointestinal symptoms in the elderly: a population-based study.

Authors:  N J Talley; E A O'Keefe; A R Zinsmeister; L J Melton
Journal:  Gastroenterology       Date:  1992-03       Impact factor: 22.682

Review 8.  Nurses, bowel continence, stigma, and taboos.

Authors:  Christine Norton
Journal:  J Wound Ostomy Continence Nurs       Date:  2004 Mar-Apr       Impact factor: 1.741

9.  The impact of incontinence on health-related quality of life in a South Australian population sample.

Authors:  Jodie C Avery; Tiffany K Gill; Alastair H MacLennan; Catherine R Chittleborough; Janet F Grant; Anne W Taylor
Journal:  Aust N Z J Public Health       Date:  2004-04       Impact factor: 2.939

10.  Epidemiology of fecal incontinence: the silent affliction.

Authors:  J F Johanson; J Lafferty
Journal:  Am J Gastroenterol       Date:  1996-01       Impact factor: 10.864

View more
  9 in total

1.  Faecal incontinence and health related quality of life in inflammatory bowel disease patients: Findings from a tertiary care center in South Asia.

Authors:  Duminda Subasinghe; Navarathna Mudiyanselage Meththananda Navarathna; Dharmabandhu Nandadeva Samarasekera
Journal:  World J Gastrointest Pharmacol Ther       Date:  2016-08-06

2.  "It's just horrible": a qualitative study of patients' and carers' experiences of bowel dysfunction in multiple sclerosis.

Authors:  Lesley Dibley; Maureen Coggrave; Doreen McClurg; Sue Woodward; Christine Norton
Journal:  J Neurol       Date:  2017-05-26       Impact factor: 4.849

3.  Impact of fecal incontinence on quality of life.

Authors:  Lynne Bartlett; Madeleine Nowak; Yik-Hong Ho
Journal:  World J Gastroenterol       Date:  2009-07-14       Impact factor: 5.742

4.  A Qualitative Study of Health Care Professionals' Views on Bowel Care in Multiple Sclerosis: Whose Job Is It Anyway?

Authors:  Sue Woodward; Maureen Coggrave; Lesley Dibley; Doreen McClurg; Christine Norton
Journal:  Int J MS Care       Date:  2021-06-15

5.  Tools for fecal incontinence assessment: lessons for inflammatory bowel disease trials based on a systematic review.

Authors:  Ferdinando D'Amico; Steven D Wexner; Carolynne J Vaizey; Célia Gouynou; Silvio Danese; Laurent Peyrin-Biroulet
Journal:  United European Gastroenterol J       Date:  2020-07-17       Impact factor: 4.623

6.  On the prevalence of constipation and fecal incontinence, and their co-occurrence, in the Netherlands.

Authors:  Rob J Meinds; Maxime M van Meegdenburg; Monika Trzpis; Paul M A Broens
Journal:  Int J Colorectal Dis       Date:  2016-12-02       Impact factor: 2.571

7.  Libertas: a phase II placebo-controlled study of NRL001 in patients with faecal incontinence showed an unexpected and sustained placebo response.

Authors:  L Siproudhis; W Graf; A Emmanuel; D Walker; R Ng Kwet Shing; C Pediconi; J Pilot; S Wexner; J Scholefield
Journal:  Int J Colorectal Dis       Date:  2016-04-13       Impact factor: 2.571

Review 8.  Functional gastrointestinal disorders in inflammatory bowel disease: Time for a paradigm shift?

Authors:  Dipesh H Vasant; Alexander C Ford
Journal:  World J Gastroenterol       Date:  2020-07-14       Impact factor: 5.742

9.  Understanding what impacts on disclosing anal incontinence for women when comparing bowel-screening tools: a phenomenological study.

Authors:  Julie Tucker; Elizabeth Mary Ann Murphy; Mary Steen; Vicki L Clifton
Journal:  BMC Womens Health       Date:  2019-11-21       Impact factor: 2.809

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.